• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌的中枢神经系统转移

Central nervous system metastases in breast cancer.

作者信息

Kiricuta I C, Kölbl O, Willner J, Bohndorf W

机构信息

Clinic and Policlinic for Radiotherapy, University of Würzburg, Federal Republic of Germany.

出版信息

J Cancer Res Clin Oncol. 1992;118(7):542-6. doi: 10.1007/BF01225270.

DOI:10.1007/BF01225270
PMID:1624546
Abstract

Sixty-two breast cancer patients with central nervous system (CNS) metastases were reviewed. The CNS was the first site of metastatic involvement in 38 cases (61%). The median survival from the primary diagnosis was 3.0 years; from the diagnosis of the CNS metastasis, 6 months. The interval between primary diagnosis and CNS metastasis had a median value of 2.0 years; between the initial extra-cranial metastasis and CNS metastasis this was 0.9 years. Prognostic factors for the appearance of CNS metastasis could not be identified. Subsequent to CNS metastasis appearing, the well-known prognostic factors for the survival time and the metastasis-free interval lose their importance. Brain metastases occur, above all, in patients aged between 50 and 55 years, very often in the first 2.5 years after the first distant metastasis and not later than 10 years from the primary diagnosis.

摘要

对62例发生中枢神经系统(CNS)转移的乳腺癌患者进行了回顾性研究。在38例(61%)患者中,CNS是转移累及的首个部位。从初次诊断开始计算的中位生存期为3.0年;从中枢神经系统转移诊断开始计算为6个月。初次诊断与中枢神经系统转移之间的间隔中位值为2.0年;初次颅外转移与中枢神经系统转移之间的间隔为0.9年。无法确定中枢神经系统转移出现的预后因素。中枢神经系统转移出现后,众所周知的生存时间和无转移间期的预后因素就失去了重要性。脑转移主要发生在年龄在50至55岁之间的患者中,通常在首次远处转移后的头2.5年内,且不晚于初次诊断后的10年。

相似文献

1
Central nervous system metastases in breast cancer.乳腺癌的中枢神经系统转移
J Cancer Res Clin Oncol. 1992;118(7):542-6. doi: 10.1007/BF01225270.
2
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
3
A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.一项关于恶性脊柱转移瘤的证据的系统回顾:自然病史和识别高风险椎体骨折和脊髓压迫患者的技术。
Health Technol Assess. 2013 Sep;17(42):1-274. doi: 10.3310/hta17420.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.缺失数据的存在是否会影响 SORG 机器学习算法在脊柱转移瘤患者中的性能?开发一种互联网应用算法。
Clin Orthop Relat Res. 2024 Jan 1;482(1):143-157. doi: 10.1097/CORR.0000000000002706. Epub 2023 Jun 12.
7
A retrospective study at a single center examining risk factors associated with central nervous system involvement in individuals diagnosed with diffuse large B-cell lymphoma.一项在单一中心进行的回顾性研究,该研究考察了被诊断为弥漫性大B细胞淋巴瘤的个体中与中枢神经系统受累相关的风险因素。
Clin Neurol Neurosurg. 2024 Sep;244:108454. doi: 10.1016/j.clineuro.2024.108454. Epub 2024 Jul 14.
8
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
9
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
10
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.

引用本文的文献

1
Temporal Dynamics and Clinical Predictors of Brain Metastasis in Breast Cancer: A Two-Decade Cohort Analysis Toward Tailored CNS Screening.乳腺癌脑转移的时间动态变化及临床预测因素:针对个体化中枢神经系统筛查的二十年队列分析
Cancers (Basel). 2025 Mar 11;17(6):946. doi: 10.3390/cancers17060946.
2
Role of Radiosurgery in the Treatment of Brain Metastasis.立体定向放射外科在脑转移瘤治疗中的作用
Fed Pract. 2015 Oct;32(10):32-37.
3
Investigating the causes of vertigo in breast cancer survivors.探究乳腺癌幸存者眩晕的病因。

本文引用的文献

1
Central nervous system metastasis from breast carcinoma. Autopsy study.乳腺癌的中枢神经系统转移。尸检研究。
Cancer. 1983 Dec 15;52(12):2349-54. doi: 10.1002/1097-0142(19831215)52:12<2349::aid-cncr2820521231>3.0.co;2-b.
2
Chemotherapy induces regression of brain metastases in breast carcinoma.化疗可使乳腺癌脑转移灶消退。
Cancer. 1986 Aug 15;58(4):832-9. doi: 10.1002/1097-0142(19860815)58:4<832::aid-cncr2820580404>3.0.co;2-w.
3
Proliferative potential of brain metastases.脑转移瘤的增殖潜能
Eur Arch Otorhinolaryngol. 2005 May;262(5):432-6. doi: 10.1007/s00405-004-0846-5. Epub 2004 Sep 18.
4
Ten years disease-free survival after solitary brain metastasis from breast cancer.乳腺癌孤立性脑转移后十年无病生存
J Cancer Res Clin Oncol. 1996;122(9):570-2. doi: 10.1007/BF01213556.
Cancer. 1988 Aug 1;62(3):512-5. doi: 10.1002/1097-0142(19880801)62:3<512::aid-cncr2820620312>3.0.co;2-j.
4
The natural history of breast cancer patients with brain metastases.伴有脑转移的乳腺癌患者的自然病史。
Cancer. 1979 Nov;44(5):1913-8. doi: 10.1002/1097-0142(197911)44:5<1913::aid-cncr2820440554>3.0.co;2-d.